EWO1 in Persistent Allergic Rhinitis Patients

Summary

The aim of this double-blind, randomized, parallel group, placebo-controlled study is to assess the efficacy and safety of EWO1 in patients with moderate to severe perennial allergic rhinitis (AR).

Timeline

Start

2004-11

Primary completion

—

Completion

—

Drugs

Indications